Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

BACKGROUND: Haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable identical donors and those who are refractory to immunosuppressive therapy (IST). The current study evaluated the feasib...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lan-Ping, Jin, Song, Wang, Shun-Qing, Xia, Ling-Hui, Bai, Hai, Gao, Su-Jun, Liu, Qi-Fa, Wang, Jian-Min, Wang, Xin, Jiang, Ming, Zhang, Xi, Wu, De-Pei, Huang, Xiao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251320/
https://www.ncbi.nlm.nih.gov/pubmed/28107815
http://dx.doi.org/10.1186/s13045-017-0398-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251320/
https://www.ncbi.nlm.nih.gov/pubmed/28107815
http://dx.doi.org/10.1186/s13045-017-0398-y

Ejemplares similares